| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | Cencora, Inc. Common Stock [ | May 6, 2026 | |
| Sell | Cencora, Inc. Common Stock [ | May 6, 2026 | |
| Buy | Cencora, Inc. Common Stock [ | Mar 31, 2026 | |
| Buy | Cencora, Inc. Common Stock | Mar 27, 2026 | |
| Buy | Cencora, Inc. Common Stock [ | Mar 23, 2026 | |
| Buy | Cencora, Inc. Common Stock [ | Mar 23, 2026 | |
| Sell | CENCORA INC | Aug 22, 2025 | |
| Sell | CENTENE CORPORATION CMN | Aug 4, 2025 | |
| Buy | CENTENE CORPORATION CMN | May 28, 2025 | |
| Sell | CENCORA CORPORATION CMN | May 19, 2025 |
This page tracks congressional stock trading activity in Cencora, Inc. (COR) in the Healthcare sector. Disclosed Capitol has indexed 37 disclosed congressional trades involving COR. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 37 disclosed congressional trades in Cencora, Inc. (COR) — 15:13 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| May 6, 2026 | Jared Moskowitz | D | Sell | $1,001 - $15,000 |
| May 6, 2026 | Jared Moskowitz | D | Sell | $1,001 - $15,000 |
| Mar 31, 2026 | Jared Moskowitz | D | Buy | $1,001 - $15,000 |
| Mar 27, 2026 | Alan Armstrong | R | Buy | $1,001 - $15,000 |
| Mar 23, 2026 | Jared Moskowitz | D | Buy | $1,001 - $15,000 |
| Mar 23, 2026 | Jared Moskowitz | D | Buy | $1,001 - $15,000 |
| Aug 22, 2025 | Michael McCaul | R | Sale | $1,001 - $15,000 |
| Aug 4, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| May 28, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| May 19, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
Across the 37 disclosed congressional trades in Cencora, Inc. (COR), members of Congress have reported 13 buys and 15 sells. The average 30-day alpha vs. the S&P 500 is -0.99%.
For fiscal year 2025, Cencora, Inc. reported revenue of $321.33B and net income of $1.55B, per SEC filings.
Most recent reported quarter: Q3 FY2026 — revenue $84.75B, net income $763.5M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.